Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL656963 | 0.96 | CHRNA7 (0.33) | — | |
| SCHEMBL18960 | 0.96 | — | — | |
| SCHEMBL28421467 | 0.92 | — | — | |
| SCHEMBL9349701 | 0.92 | CHRNA7 (0.32) | — | |
| Hydrochloric Acid SCHEMBL28596120 | 0.92 | CHRNA7 (0.32) | — | |
| Water SCHEMBL1542414 | 0.92 | CHRNA7 (0.32) | — | |
| Bromide SCHEMBL156131 | 0.92 | — | — | |
| SCHEMBL9232705 | 0.92 | — | — | |
| Fluoride SCHEMBL2112417 | 0.92 | CHRNA7 (0.32) | — | |
| SCHEMBL538360 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0159059-B1 | COMPOUNDS WITH ANTI-BRONCHOSPASTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Laboratori Guidotti S.p.A. (IT) | 1988-12-14 | — | — | EP | claimed |
| US-9968917-B2 | LEV-type zeolite and production method therefor | TOSOH CORPORATION (JP) | 2018-05-15 | — | — | US | disclosed |
| US-20160121316-A1 | LEV-TYPE ZEOLITE AND PRODUCTION METHOD THEREFOR | TOSOH CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| EP-3009400-A1 | LEV-TYPE ZEOLITE AND PRODUCTION METHOD THEREFOR | Tosoh Corporation (JP) | 2016-04-20 | — | — | EP | disclosed |
| US-8772314-B2 | Glycine derivatives and medicinal compositions thereof | CHIESI FARMACEUTICI S.P.A. (IT) | 2014-07-08 | — | — | US | disclosed |
| EP-2643295-A1 | GLYCINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS | Chiesi Farmaceutici S.p.A. (IT) | 2013-10-02 | — | — | EP | disclosed |
| US-20120134934-A1 | GLYCINE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-05-31 | — | — | US | disclosed |
| WO-2012069275-A1 | GLYCINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-05-31 | — | — | WO | disclosed |
| US-RE41226-E1 | Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2010-04-13 | — | — | US | disclosed |
| US-RE40861-E1 | Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase | Sigma-Tau Industrie Farmaceutiche Reunite S.p.A. (IT) | 2009-07-21 | — | — | US | disclosed |
| US-20020052348-A1 | Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. | 2002-05-02 | — | — | US | disclosed |
| US-6369073-B1 | HYPERGLYCEMIA, DIABETES, HEART FAILURE, ISCHEMIA | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2002-04-09 | — | — | US | disclosed |
| EP-1077925-A1 | COMPOUNDS HAVING REVERSIBLE INHIBITING ACTIVITY OF CARNITINE PALMITOYL-TRANSFERASE | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2001-02-28 | — | — | EP | disclosed |
| WO-1999059957-A1 | COMPOUNDS HAVING REVERSIBLE INHIBITING ACTIVITY OF CARNITINE PALMITOYL-TRANSFERASE | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1999-11-25 | — | — | WO | disclosed |
| EP-0159059-B1 | COMPOUNDS WITH ANTI-BRONCHOSPASTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Laboratori Guidotti S.p.A. (IT) | 1988-12-14 | — | — | EP | disclosed |
| EP-0040015-B1 | PROCESS FOR MAKING OLEFINS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-06-11 | — | — | EP | disclosed |
| US-4589977-A | HYDROCRACKING CATALYST | CHEVRON RESEARCH COMPANY (US) | 1986-05-20 | — | — | US | disclosed |
| US-4510256-A | CATALYST AND ADSORBENT | CHEVRON RESEARCH COMPANY (US) | 1985-04-09 | — | — | US | disclosed |
| US-4361715-A | CATALYZED BY ZEOLITE NU-3 | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-11-30 | — | — | US | disclosed |
| EP-0040015-A1 | Process for making olefins | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-11-18 | — | — | EP | disclosed |